Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review (original) (raw)

Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention

Alex J Mitchell

Advances in Psychiatric Treatment, 2006

View PDFchevron_right

Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia

Shiv Shankar

Cardiology research and practice, 2014

View PDFchevron_right

Association between antipsychotics and cardiovascular adverse events: A systematic review

Célio de Sousa-Rodrigues

Revista da Associação Médica Brasileira, 2017

View PDFchevron_right

Cardiovascular risks of atypical antipsychotic drug treatment

Milou-daniel Drici

Pharmacoepidemiology and Drug Safety, 2007

View PDFchevron_right

Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach

Aleksey Tentler

Journal of Multidisciplinary Healthcare, 2014

View PDFchevron_right

Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States

Warren Bilker

Journal of clinical & experimental cardiology, 2013

View PDFchevron_right

A systematic review of cardiovascular effects after atypical antipsychotic medication overdose

Jason Hoppe

The American Journal of Emergency Medicine, 2009

View PDFchevron_right

Antipsychotics and associated risk of out-of-hospital cardiac arrest

Erika Christensen

Clinical pharmacology and therapeutics, 2014

View PDFchevron_right

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data

Warren Bilker

BMJ, 2002

View PDFchevron_right

Psychopharmacology: Cardiac Effects of Antipsychotic Medications

mariam fayek

Psychiatric Services, 2001

View PDFchevron_right

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

Ian Douglas

British Journal of Clinical Pharmacology, 2011

View PDFchevron_right

Sudden cardiac death secondary to antidepressant and antipsychotic drugs

Charles Antzelevitch

Expert Opinion on Drug Safety, 2008

View PDFchevron_right

Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system

Ric Procyshyn

Pharmacology & Therapeutics, 2012

View PDFchevron_right

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

Robert Bodén

Neuropsychiatric Disease and Treatment, 2013

View PDFchevron_right

Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study

Adam Timmis, Harry Hemingway

Eur Heart J, 2014

View PDFchevron_right

Association between antipsychotic use and risk of acute myocardial infarction: a nationwide case-crossover study

Kai-da Cheng

Circulation, 2014

View PDFchevron_right

Antipsychotic Treatment and Mortality in Schizophrenia

Charlotte Björkenstam, Minna Torniainen-Holm, Kristina Alexanderson

Schizophrenia Bulletin, 2014

View PDFchevron_right

Antipsychotics and the Risk of Mortality or Cardiopulmonary Arrest in Hospitalized Adults

Wenxiao Zhou

Journal of the American Geriatrics Society, 2019

View PDFchevron_right

5The Journal of Tehran Heart Center Review Article Antipsychotic Drugs and Sudden Death

Shahin Akhondzadeh

2016

View PDFchevron_right

Antipsychotics in Treatment of Schizophrenic Patients with Past Medical History of Coronary Artery Disease

Dr. Marjan Assefi

Journal of Critical Care & Emergency Medicine

View PDFchevron_right

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine

Heidi Wehring

The Journal of Clinical Psychiatry, 2010

View PDFchevron_right

Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice

Mireille Canal-raffin

Toxicology and Applied Pharmacology, 2004

View PDFchevron_right

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

Marc Hert

Nature Reviews Endocrinology - NAT REV ENDOCRINOL, 2011

View PDFchevron_right

Influence of antipsychotics on mortality in schizophrenia: evidence from observational studies

Sheila Weinmann

Pharmacopsychiatry, 2009

View PDFchevron_right

Cardiovascular Toxicity as a Result of Psychotropic Drugs

Mythily Subramaniam

Heart and Toxins, 2015

View PDFchevron_right

Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death

Vittorio Fineschi

Journal of Geriatric Cardiology : JGC, 2021

View PDFchevron_right

Atypical Antipsychotics and Cardiovascular Risk in Schizophrenic Patients

roch-hugo bouchard

Journal of Clinical Psychopharmacology, 2001

View PDFchevron_right

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

jeffrey lieberman

Schizophrenia Research, 2008

View PDFchevron_right

Cardiovascular effects of psychotropic drugs

Robert Feinstein

Current problems in cardiology, 2002

View PDFchevron_right

Atypical Antipsychotics: From Potassium Channels to Torsade de Pointes and Sudden Death

Nicholas Moore

Drug Safety, 2005

View PDFchevron_right